| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 29.120 | 37.561 | 45.869 | 40.938 | 45.146 | 43.344 | 53.614 | 53.921 | 57.437 | 90.146 |
| Total Income - EUR | 29.791 | 37.561 | 47.051 | 42.412 | 45.335 | 46.584 | 53.614 | 53.921 | 57.437 | 90.146 |
| Total Expenses - EUR | 23.382 | 28.042 | 49.293 | 43.240 | 51.231 | 48.558 | 56.336 | 47.406 | 69.083 | 87.623 |
| Gross Profit/Loss - EUR | 6.409 | 9.520 | -2.242 | -829 | -5.895 | -1.974 | -2.722 | 6.515 | -11.646 | 2.523 |
| Net Profit/Loss - EUR | 5.515 | 9.144 | -4.539 | -1.241 | -6.347 | -2.233 | -3.022 | 5.976 | -12.220 | -127 |
| Employees | 2 | 2 | 3 | 3 | 2 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Parodent Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 39.879 | 60.493 | 55.872 | 50.222 | 44.917 | 39.939 | 35.636 | 31.762 | 20.302 | 16.780 |
| Current Assets | 8.926 | 22.129 | 7.002 | 5.020 | 7.289 | 9.772 | 4.802 | 6.589 | 5.842 | 12.805 |
| Inventories | 920 | 5.196 | 1.313 | 87 | 0 | 0 | 0 | 0 | 0 | 2.776 |
| Receivables | 1.407 | 1.058 | 1.385 | 1.025 | 1.005 | 1.463 | 1.390 | 1.395 | 3.831 | 2.607 |
| Cash | 6.599 | 15.875 | 4.304 | 3.908 | 6.284 | 8.309 | 3.411 | 5.195 | 2.012 | 7.422 |
| Shareholders Funds | 30.149 | 38.985 | 33.787 | 31.926 | 24.960 | 22.644 | 19.120 | 23.304 | 11.013 | 10.825 |
| Social Capital | 1.125 | 1.113 | 1.095 | 1.074 | 1.054 | 1.034 | 1.011 | 1.014 | 1.011 | 1.005 |
| Debts | 18.656 | 43.674 | 29.087 | 23.317 | 27.246 | 27.067 | 21.318 | 15.048 | 15.131 | 18.760 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8623 - 8623" | |||||||||
| CAEN Financial Year |
8623
|
|||||||||
Comments - Parodent Med Srl